Effect rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes

Authors

B. Zinman
S. M. Haffner
W. H. Herman
R. R. Holman
J. M. Lachin

Document Type

Journal Article

Publication Date

2010

Journal

Journal of Clinical Endocrinology and Metabolism

Volume

95

Issue

1

Inclusive Pages

134-142

APA Citation

Zinman, B., Haffner, S., Herman, W., Holman, R., & Lachin, J. (2010). Effect rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 95 (1). Retrieved from https://hsrc.himmelfarb.gwu.edu/sphhs_epibiostats_facpubs/1056